ScienceDirect - Journal of Molecular Biology : The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of α-Synuclein Aggregation Leading to the Formation of Nontoxic Species
Links shared publicly online about this topic.
- 743total visits
ScienceDirect - Journal of Molecular Biology : The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of α-Synuclein Aggregation Leading to the Formation of Nontoxic Species
ScienceDirect - Journal of Molecular Biology : The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of α-Synuclein Aggregation Leading to the Formation of Nontoxic Species
View full resource at sciencedirect.com
Tags: Parkinson's Disease, Parkinson's Disease Medication, Drug, Eldepryl, Deprenyl, Science
Most Recently Shared on November 8, 2010 at 7:59 am By:
Selegiline delays alpha-synuclein aggregation and may slow down Lewy body formation in Parkinson's. http://tinyurl.com/32pyy7e
Advertisement
